Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Fisher Drug Discovery Resource Center

The Rockefeller University is the world’s leading biomedical research University. Our groundbreaking discoveries in basic and clinical research are transforming medicine.  The Fisher Drug Discovery Resource Center (DDRC) guides and supports our researchers in drug discovery by improving the efficiency of their bioassays, identifying compounds for drug refinement and development, understanding the targets for drugs, and in providing technologies for the measurement of drug/receptor interactions. The center has a collection of 420,000 drug-like compounds, along with semi-automated liquid pipetting devices, and bioassay instruments for supporting drug discovery programs.  The center also houses biophysical instruments for use in studies of the interactions of drugs with their targets. (RRID:SCR_020985)

Please contact our staff at ddrc@rockefeller.edu if you are interested in using our facility.

The Drug Discovery Process

 

The DDRC supports the following areas:

    • developing assay cascades for drug discovery projects
    • miniaturized assay development
    • high-throughput screening
    • identifying compounds for drug discovery or biomedical research
    • measuring the kinetics and thermodynamics of biomolecular interactions

Fisher Drug Discovery Resource Center Lecture, June 1, 2022

Meeting Recording:  https://rocku.zoom.us/rec/share/x5Da7xNCaiKRZJDrCE4_Ge02s-XwSi5nJ-  KJUW91Vou-WhkgHfc6ssTIT1mu6UcE.5Wx3SS_Db-6ijxTQ

Access Passcode: X*wnCij1

Initiating a project with us

If you are interested please contact ddrc@rockefeller.edu. Drug discovery typically requires a significant financial and time commitment and advance discussions are needed to prepare. This resource center is a shared facility supported by Weill-Cornell Medical College and The Rockefeller University, and we welcome clients from those institutions. Due to a high demand for our services, we can accept projects from outside institutions only on a case-by-case basis. The DDRC does not currently support research in conjunction with for-profit entities.

The high-throughput screening process